1 181

Cited 11 times in

Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations

Authors
 Dong-Wook Han  ;  Jun Jae Lee  ;  Duk-Young Jung  ;  Jong-Chul Park  ;  Suong-Hyu Hyon 
Citation
 BIOMEDICAL MATERIALS, Vol.4(4) : 044104, 2009 
Journal Title
 BIOMEDICAL MATERIALS 
ISSN
 1748-6041 
Issue Date
2009
MeSH
Animals ; Aorta, Thoracic/cytology ; Caproates ; Catechin/analogs & derivatives ; Catechin/metabolism ; Drug Delivery Systems/adverse effects ; Drug-Eluting Stents* ; Lactones ; Male ; Muscle, Smooth, Vascular/cytology ; Muscle, Smooth, Vascular/metabolism ; Myocytes, Smooth Muscle/cytology ; Myocytes, Smooth Muscle/metabolism ; Polymers/metabolism ; Rats ; Rats, Sprague-Dawley ; Stents/adverse effects* ; Tensile Strength
Abstract
Localized drug delivery from drug-eluting stents has been accepted as one of the most promising treatment methods for preventing restenosis after stenting. However, hypersensitivity reactions caused by their nonresorbable polymer coatings and bare-metal stents may result in serious clinical sequelae. Epigallocatechin-3-O-gallate (EGCG), the predominant catechin from tea, has been shown to exert anti-thrombotic, anti-inflammatory and anti-proliferative activities. in this study, it was hypothesized that sustainedly released EGCG from biodegradable poly(lactide-co-epsilon-caprolactone, PLCL) would suppress the proliferation of vascular smooth muscle cells (VSMCs). EGCG-releasing PLCL (E-PLCL) was prepared by blending PLCL with EGCG. the surface morphology, roughness and melting temperature of PLCL were not changed despite EGCG addition. EGCG was uniformly dispersed into E-PLCL and sustainedly released for periods up to 7 days by controlled diffusion rather than PLCL degradation. Moreover, EGCG did not affect tensile strength at break, but significantly increased the elastic modulus of PLCL. the proliferation of VSMCs onto E-PLCL was significantly suppressed although the cell attachment onto E-PLCL had been higher than that onto PLCL. on the other hand, EGCG-eluting polymeric stents were prepared with neither cracks nor webbings between struts, and their structural integrity was maintained without delamination or destruction. These results suggest that E-PLCL can be potentially applied for fabricating an EGCG-eluting vascular stent, namely an EGCG-eluting polymeric stent, or even an EGCG-releasing polymer-coated metal stent, to prevent thrombosis, inflammation and in-stent restenosis.
Full Text
http://stacks.iop.org/1748-6041/4/044104
DOI
10.1088/1748-6041/4/4/044104
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Medical Engineering (의학공학교실) > 1. Journal Papers
Yonsei Authors
Park, Jong Chul(박종철) ORCID logo https://orcid.org/0000-0003-0083-5991
Han, Dong Wook(한동욱)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/104718
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse